EUCTR2012-001100-38-IT进行中（未招募）1 期
Antagonists of Angiotensin II Receptors in sepsis
DIPART. DI NEUROSCIENZE, SCIENZE RIPRODUTTIVE E ODONTOSTOMATOLOGICHE DELL’UNIVERSITà DEGLI STUDI DI NAPOLI FEDERICO II0 个研究点目标入组 300 人开始时间: 2014年4月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with severe sepsis, hospitalised in the Intensive Care Unit, but able to give the informed consent; Female and Male; Age between 18 and 75 years old; sepsis evaluated wth the publications of the American College of Chest Physician/Society of Critical Care Medicine; multiple organ failure measured by SOFA (Sequential Organ Failure Assessment) score
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 240
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 60
排除标准
- •Pregnancy; nursing; pre-existen renal damage (severe renal failure or creatinine value of 2,0 mg/dL or dialysis); patient in treatment with ACE inhibitors or ARBs; shock conditions (systolic blood pressure lower than 90 mmHg): patients inserted, in the previous 12 weeks, in another clinical trial that uses another farmaceutical product; known allergies to ARBs
研究者
相似试验
Unknown
不适用
Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.SepsisSeptic ShockNCT04716842Inonu University75
已完成
4 期
Therapeutic Efficacy of an Angiotensin II Receptor Antagonist in Patients with Nonalcoholic Steathepatitisonalcoholic steatohepatitisJPRN-C000000202Gunma Liver Study Group10
进行中（未招募）
不适用
ACE-inhibitors and Angiotensin two receptor antagonists in IgA nephropathy with mild proteinuriaThe primary aim of the study consists in testing the hypothesis that blockade of the RAS may decrease the risk of developing adverse effects in patients with benign IgAN.Such blockade would first achieved with unique pharmacological class then shifting to the association of the two classes as soon as ineffective blockade is documentedMedDRA version: 9.1Level: SOCClassification code 10038359Term: Renal and urinary disordersEUCTR2005-003885-40-ITAZIENDA OSPEDALIERA PROVINCIALE DI LECCO
已完成
不适用
Impact of angiotensin II receptor antagoniston on adriamycin-induced cardiomyopathyMarignancy patients who will treat with adriamycinJPRN-UMIN000005066Division of Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine100
招募中
不适用
Angiotensin receptor-neprilysin inhibitor in patients with acute myocardial infarction and heart failureAcute myocardial infarctionJPRN-UMIN000046004Chiba University Hospital1,000